An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed.

CVD ECM RAAS TGF-β arterial stiffness vascular fibrosis

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2023
Historique:
received: 06 08 2023
accepted: 27 11 2023
medline: 5 1 2024
pubmed: 5 1 2024
entrez: 5 1 2024
Statut: epublish

Résumé

Vascular fibrosis is a widespread pathologic condition that arises during vascular remodeling in cardiovascular dysfunctions. According to previous studies, vascular fibrosis is characterized by endothelial matrix deposition and vascular wall thickening. The RAAS and TGF-β/Smad signaling pathways have been frequently highlighted. It is, however, far from explicit in terms of understanding the cause and progression of vascular fibrosis. In this review, we collected and categorized a large number of molecules which influence the fibrosing process, in order to acquire a better understanding of vascular fibrosis, particularly of pathologic dysfunction. Furthermore, several mediators that prevent vascular fibrosis are discussed in depth in this review, with the aim that this will contribute to the future prevention and treatment of related conditions.

Identifiants

pubmed: 38179503
doi: 10.3389/fcvm.2023.1273502
pmc: PMC10764515
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1273502

Informations de copyright

© 2023 Hua, Gao, He, Xin, Wang, Zhang, Gao, Tao, Wu, Sun and Xu.

Déclaration de conflit d'intérêts

The author(s) declare financial support was received for the research, authorship, and/or publication of this article.

Auteurs

Rongxuan Hua (R)

Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, China.

Han Gao (H)

Department of Clinical Laboratory, Aerospace Center Hospital, Peking University, Beijing, China.
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.

Chengwei He (C)

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.

Shuzi Xin (S)

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.

Boya Wang (B)

State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing, China.

Sitian Zhang (S)

Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, China.

Lei Gao (L)

Department of Biomedical Informatics, School of Biomedical Engineering, Capital Medical University, Beijing, China.

Qiang Tao (Q)

Department of Biomedical Informatics, School of Biomedical Engineering, Capital Medical University, Beijing, China.

Wenqi Wu (W)

Experimental Center for Morphological Research Platform, Capital Medical University, Beijing, China.

Fangling Sun (F)

Department of Experimental Animal Laboratory, Xuan-Wu Hospital of Capital Medical University, Beijing, China.

Jingdong Xu (J)

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.

Classifications MeSH